Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

$1.8 billion arms sale to Taiwan given China's aggression. Hopes For Armenia-Azerbaijan Deal Fade Despite Upcoming Pompeo Meeting. Reuters (10/22, Bagirova, Hovhannisyan) reports that "hopes of ending nearly a month of bloodshed in the mountain enclave of Nagorno-Karabakh looked slim on Thursday as Azer

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

. Reuters <https://www.reuters.corn/article/us-armenia-azerbaijanrnagorno-karabakh-peace-hopes-slim-before- washington-talks-idUSICBN277171> (10/22, Bagirova, Hovhannisyan) reports that "hopes of ending nearly a month of bloodshed in the mountain enclave of Nagorno-Karabakh looked slim on Thursday as Azer

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

$1.8 billion arms sale to Taiwan given China's aggression. Hopes For Armenia-Azerbaijan Deal Fade Despite Upcoming Pompeo Meeting. Reuters (10/22, Bagirova, Hovhannisyan) reports that "hopes of ending nearly a month of bloodshed in the mountain enclave of Nagorno-Karabakh looked slim on Thursday as Azer